Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
Oncology Today with Dr Neil Love
00:00
Role of pirtobrutinib and BTK degraders ahead
Tam expects pirtobrutinib useful for time-limited regimens; he doubts degraders will move to frontline soon.
Play episode from 44:58
Transcript
